PETS
PETMED EXPRESS INC
Overview
PetMed Express operates an online pharmacy that sells prescription and over-the-counter medications, food, and wellness products for dogs, cats, and horses directly to consumers through its PetMeds.com and PetCareRx.com websites, mobile apps, and customer service centers.
PETMED EXPRESS INC is a Healthcare company operating in Pharmaceutical Retailers with a $37.4M market cap.
PETS missed consensus EPS by 0.1% in Q1 FY2026, reported Jun 1, 2026.
16 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q3 FY2025Earnings2025-02-109 Q&A exchanges
- Q2 FY2025Earnings2024-11-065 Q&A exchanges
- Q1 FY2025Earnings2024-08-064 Q&A exchanges
- Q4 FY2024Earnings2024-06-115 Q&A exchanges
- Q4 FY2023Earnings2024-06-114 Q&A exchanges
- Q3 FY2023Earnings2024-02-084 Q&A exchanges
- Q2 FY2023Earnings2023-10-302 Q&A exchanges
- Q1 FY2023Earnings2023-07-319 Q&A exchanges
- Q4 FY2022Earnings2023-05-225 Q&A exchanges
- Q3 FY2022Earnings2023-02-069 Q&A exchanges
- Q2 FY2022Earnings2022-11-075 Q&A exchanges
- Q1 FY2022Earnings2022-07-2510 Q&A exchanges
- Q4 FY2021Earnings2022-05-097 Q&A exchanges
- Q3 FY2021Earnings2022-01-2415 Q&A exchanges
- Q2 FY2021Earnings2021-10-257 Q&A exchanges
- Q1 FY2021Earnings2021-07-2614 Q&A exchanges
History
Earnings history
- Q1 FY20262026-06-01EPS$-0.19 vs $-0.18-5.6%Rev$42.8M vs ——EODHD
- Q4 FY20252026-02-04EPS$-0.50 vs $-0.06-100.0%Rev$40.7M vs ——EODHD
- Q3 FY20252025-10-13EPS$-0.56 vs $-0.49-14.3%Rev$44.4M vs ——EODHD
- Q2 FY20252025-08-10EPS$-0.06 vs $0.21-100.0%Rev$51.2M vs ——EODHD
- Q1 FY20252025-06-08EPS$-0.34 vs $-0.04-100.0%Rev— vs ——EODHD
- Q4 FY20242024-06-10EPS$-0.25 vs $-0.07-100.0%Rev$66.5M vs ——EODHD
- Q3 FY20232024-02-07EPS$-0.10 vs $-0.01-100.0%Rev$65.3M vs ——EODHD
- Q2 FY20232023-10-29EPS$-0.00 vs $0.09-100.0%Rev$71.0M vs ——EODHD
- Q1 FY20232023-07-30EPS$0.10 vs $0.07+42.9%Rev$78.2M vs ——EODHD
- Q4 FY20222023-05-21EPS$-0.25 vs $0.14-100.0%Rev$62.4M vs ——EODHD
- Q3 FY20222023-02-05EPS$0.02 vs $0.17-88.2%Rev$58.9M vs ——EODHD
- Q2 FY20222022-11-06EPS$0.17 vs $0.26-34.6%Rev$65.4M vs ——EODHD
- Q1 FY20222022-07-24EPS$0.15 vs $0.23-34.8%Rev$70.2M vs ——EODHD
- Q4 FY20212022-05-08EPS$0.30 vs $0.28+7.1%Rev$66.0M vs ——EODHD
- Q3 FY20212022-01-23EPS$0.21 vs $0.32-34.4%Rev$60.7M vs ——EODHD
- Q2 FY20212021-10-24EPS$0.31 vs $0.35-11.4%Rev$67.4M vs ——EODHD
- Q1 FY20212021-07-25EPS$0.23 vs $0.35-34.3%Rev$79.3M vs ——EODHD
- Q4 FY20202021-01-18EPS$0.38 vs $0.380.0%Rev$65.9M vs ——EODHD
- Q3 FY20202020-10-25EPS$0.42 vs $0.40+5.0%Rev$75.4M vs ——EODHD
- Q2 FY20202020-07-19EPS$0.39 vs $0.40-2.5%Rev$96.2M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q1 FY2026 | 2026-06-01 | $-0.19 | $-0.18 | -5.6% | $42.8M | — | — | EODHD |
| Q4 FY2025 | 2026-02-04 | $-0.50 | $-0.06 | -100.0% | $40.7M | — | — | EODHD |
| Q3 FY2025 | 2025-10-13 | $-0.56 | $-0.49 | -14.3% | $44.4M | — | — | EODHD |
| Q2 FY2025 | 2025-08-10 | $-0.06 | $0.21 | -100.0% | $51.2M | — | — | EODHD |
| Q1 FY2025 | 2025-06-08 | $-0.34 | $-0.04 | -100.0% | — | — | — | EODHD |
| Q4 FY2024 | 2024-06-10 | $-0.25 | $-0.07 | -100.0% | $66.5M | — | — | EODHD |
| Q3 FY2023 | 2024-02-07 | $-0.10 | $-0.01 | -100.0% | $65.3M | — | — | EODHD |
| Q2 FY2023 | 2023-10-29 | $-0.00 | $0.09 | -100.0% | $71.0M | — | — | EODHD |
| Q1 FY2023 | 2023-07-30 | $0.10 | $0.07 | +42.9% | $78.2M | — | — | EODHD |
| Q4 FY2022 | 2023-05-21 | $-0.25 | $0.14 | -100.0% | $62.4M | — | — | EODHD |
| Q3 FY2022 | 2023-02-05 | $0.02 | $0.17 | -88.2% | $58.9M | — | — | EODHD |
| Q2 FY2022 | 2022-11-06 | $0.17 | $0.26 | -34.6% | $65.4M | — | — | EODHD |
| Q1 FY2022 | 2022-07-24 | $0.15 | $0.23 | -34.8% | $70.2M | — | — | EODHD |
| Q4 FY2021 | 2022-05-08 | $0.30 | $0.28 | +7.1% | $66.0M | — | — | EODHD |
| Q3 FY2021 | 2022-01-23 | $0.21 | $0.32 | -34.4% | $60.7M | — | — | EODHD |
| Q2 FY2021 | 2021-10-24 | $0.31 | $0.35 | -11.4% | $67.4M | — | — | EODHD |
| Q1 FY2021 | 2021-07-25 | $0.23 | $0.35 | -34.3% | $79.3M | — | — | EODHD |
| Q4 FY2020 | 2021-01-18 | $0.38 | $0.38 | 0.0% | $65.9M | — | — | EODHD |
| Q3 FY2020 | 2020-10-25 | $0.42 | $0.40 | +5.0% | $75.4M | — | — | EODHD |
| Q2 FY2020 | 2020-07-19 | $0.39 | $0.40 | -2.5% | $96.2M | — | — | EODHD |
Source: EODHD. PETS reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks PETS's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 8/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2025 | $3.81 | $3.92 | -2.9% | +3.7% | +2.3% |
| Q4 FY2025 | $4.03 | $4.11 | -2.0% | +4.6% | +5.1% |
| Q3 FY2025 | $3.68 | $4.07 | -9.5% | -0.5% | +1.8% |
| Q2 FY2025 | $3.78 | $4.09 | -7.5% | +6.3% | +5.7% |
| Q1 FY2024 | $4.18 | $4.18 | 0.0% | +3.8% | +2.6% |
| Q4 FY2024 | $4.22 | $4.21 | +0.3% | +2.4% | +3.1% |
| Q3 FY2024 | $3.95 | $3.97 | -0.4% | +3.5% | +2.1% |
| Q2 FY2024 | $3.98 | $4.07 | -2.2% | +6.3% | +7.3% |
| Q1 FY2023 | $3.73 | $4.07 | -8.3% | +3.3% | +4.5% |
| Q4 FY2023 | $3.91 | $4.08 | -4.1% | -0.1% | -2.6% |
Guidance change history
Sample- Q1 FY2025Maintained2025-04-15
- Q4 FY2025Maintained2025-13-15
- Q3 FY2025Lowered2025-10-15
- Q2 FY2025Lowered2025-07-15
- Q1 FY2024Maintained2024-04-15
- Q4 FY2024Maintained2024-13-15
- Q3 FY2024Maintained2024-10-15
- Q2 FY2024Maintained2024-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Douglas KrulikCFO8 mono recorded callsCurrentSample
CFO since 2025 • 1/2 beats (50%) • last call held guidance Q1 FY2025
- Sandra Yvette CamposCEO3 mono recorded callsFormerSample
CEO since 2025 • 1/2 beats (50%) • last guidance cut Q3 FY2025
- Robyn M D'eliaCFO0 mo2 callsFormerSample
CFO since 2024 • 2/4 beats (50%) • guidance suspended Q1 FY2025
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for PETS.
$ curl https://api.spokenalpha.com/v1/companies/PETSFAQ
Frequently asked about PETS
Where can I find PETMED EXPRESS INC's (PETS) earnings call transcripts?
Spoken Alpha indexes PETS's earnings call transcripts at https://spokenalpha.com/companies/PETS. Each call links to attributed speakers and parsed analyst Q&A. PETMED EXPRESS INC's own investor relations page is at https://investors.petmeds.com/overview/default.aspx.
When was PETMED EXPRESS INC's most recent earnings call?
PETMED EXPRESS INC (PETS) held its most recent earnings call on 2025-02-10, covering fiscal Q3 2025.
What sector is PETS in?
PETMED EXPRESS INC (PETS) operates in the Healthcare sector (Pharmaceutical Retailers industry).